Navigation Links
ImpactRx Releases 2010 Oncology Promotion Report
Date:1/31/2011

MOUNT LAUREL, N.J., Jan. 31, 2011 /PRNewswire/ -- ImpactRx, a pioneer in tracking and evaluating pharmaceutical promotion on the prescribing behavior of physicians, completed its annual review of the detailing efforts of pharmaceutical/biotech sales representatives in oncology offices.  The results have just been published in the January 2011 edition of Oncology Business Review.

ImpactRx's mobile pharmaceutical market research system offers a longitudinal network of 475 oncologists who use iPhone technology and proprietary software to provide real-time data about sales representative promotion, meeting and event participation and patient treatment options.  This year the data was supplemented with research into physicians' online behavior provided through a joint offering ImpactRx has with comScore, a global leader in measuring digital traffic and readership.  The result is a unique view of the promotional landscape in the fast-paced and ever-changing oncology market, helping pharmaceutical companies make the most of every minute with key physicians.

According to Richard Altus, President and CEO of ImpactRx, "Given the recent changes in the pharmaceutical and biotech industries, face time with oncologists is more valuable than ever.  This data helps refine brand and targeting strategies to ensure that the right message gets to the right physicians, providing an optimized and powerful marketing strategy."

Click here http://www.impactrx.com/pdf/OBR_93850_IMPACTRX.pdf  to download "The 3rd Annual Outlook on the Pharmaceutical Promotional Landscape within Oncology".

Key data highlighted in the article includes:

  • Share of Attention – Sales Representative Oncology Product Details 2006-2010
  • Top 25 Products Detailed by Sales Representatives 2009/2010
  • Oncology Sales Force Top Tier Rating 2010
  • Reach of Healthcare Websites  (Jan – Sept 2010)
  • Average Number of Visits per Month (Jan – Sept 2010)

  • About ImpactRx

    Founded in 2000 and headquartered in Mount Laurel, NJ, ImpactRx's longitudinal panel of high prescribing, smart phone-connected physicians is the exclusive source of continuously captured promotion and treatment data.  Through its proprietary methodology, the Company captures annually one million details and three million treatment decisions, fueling its unique industry database.  ImpactRx leverages this unprecedented intelligence with custom research and analytics to provide insightful solutions to pharmaceutical marketing and sales decision makers.  Visit ImpactRx at www.impactrx.com.CONTACT:Jennifer AguilarSagefrog Marketing Group, LLC215-230-9024jennifera@sagefrog.com
    '/>"/>

    SOURCE ImpactRx
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. ImpactRx Tracks Decline in Zetia and Vytorin Prescribing
    2. Kantar Health and ImpactRx Launch CancerMPact Monthly Drugs and Regimens for Oncology Business Decisions
    3. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
    4. CEL-SCI Corporation Releases Letter to Shareholders
    5. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
    6. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
    7. Immunosyn Corporation Releases SF-1019 Study Results
    8. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
    9. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
    10. QRxPharma Releases Successful Phase 3 Study Results for Dual Opioid Pain Therapy
    11. CenterWatch Releases State of the Clinical Trials Industry 2008 - A Key Industry Resource for Market Research and Competitive Intelligence
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/29/2017)... 2017  Glenmark Pharmaceuticals, a global pharmaceutical company, ... investigational fixed-dose combination of mometasone furoate (25 mcg) ... a nasal spray being studied for the treatment ... a recently completed Phase 3 trial assessing the ... versus mometasone, olopatadine or placebo. "We ...
    (Date:3/29/2017)...  Maxor National Pharmacy Services, LLC ("Maxor"), a leading ... Leah Bailey as General Counsel.  Bailey will serve ... With more than 13 years of experience ... on health care, Bailey joins the Maxor team coming ... advised the PBM, Specialty, and Mail Order business areas ...
    (Date:3/29/2017)... , March 29, 2017 Varian Medical Systems ... report results for the second quarter of fiscal year 2017 ... 2017.  The news release will be followed by a teleconference ... news release and a link to the conference call webcast ... .  To access the teleconference call and replay: ...
    Breaking Medicine Technology:
    (Date:3/29/2017)... ... March 29, 2017 , ... The Professional Squash Association, ... enlisted New York City-based sports and entertainment marketing firm Leverage Agency as its ... for the Professional Squash Association (PSA), which includes first-time ever title sponsorship, naming ...
    (Date:3/29/2017)... ... ... pollen is the main cause of hay fever in the United States, with an estimated ... from May to July each year; with the worst time for sufferers being June and ... ( http://www.haymax.us ) provide an effective defense against grass pollen; they are proven in independent ...
    (Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Youth Futures ... great success and feedback from high school and college students who have participated in ... held July 7-23 and YFI is now accepting applications for enrollment. Visit ...
    (Date:3/29/2017)... (PRWEB) , ... March 30, 2017 , ... Sports Brand ... brace, which retails normally at $29.97; for the remaining days of March, the ... also been reduced to a special price of just $10 (regular retail price $19.97). ...
    (Date:3/29/2017)... Louisiana (PRWEB) , ... March 29, 2017 , ... ... in three Hours at a Walgreens store in Mississippi. AngioGenesis Labs, makers of ... Walgreens Stores in two southeastern states. Ingredients in HeartBoost, an over the counter ...
    Breaking Medicine News(10 mins):